Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
55.13
-2.24 (-3.90%)
Nov 15, 2024, 4:00 PM EST - Market closed
Revolution Medicines Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -567.06 | -436.37 | -248.71 | -187.09 | -108.16 | -47.66 | Upgrade
|
| Depreciation & Amortization | 10.2 | 8.21 | 8.56 | 6.23 | 5.45 | 2.24 | Upgrade
|
| Other Amortization | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.37 | 0.05 | 0.02 | 0.12 | - | 0.82 | Upgrade
|
| Loss (Gain) From Sale of Investments | -44.37 | -22.21 | -3.08 | 3.01 | 0.97 | -0.45 | Upgrade
|
| Stock-Based Compensation | 82.19 | 61.77 | 31.2 | 20.72 | 8.89 | 3.16 | Upgrade
|
| Other Operating Activities | -4.43 | 0.12 | - | - | - | - | Upgrade
|
| Change in Accounts Receivable | 0.31 | 3.42 | 1.26 | 0.46 | 2.34 | -1.43 | Upgrade
|
| Change in Accounts Payable | -11.52 | 32.47 | 7.29 | 2.24 | 0.31 | 5.26 | Upgrade
|
| Change in Unearned Revenue | - | -4.46 | -14.47 | -1.66 | -11.26 | -13.39 | Upgrade
|
| Change in Other Net Operating Assets | -9.2 | 9.23 | -7.14 | 7.68 | 0.68 | 5.11 | Upgrade
|
| Operating Cash Flow | -539.71 | -350.57 | -224.4 | -147.18 | -100.06 | -49.62 | Upgrade
|
| Capital Expenditures | -11.4 | -7.73 | -10.82 | -6.53 | -2.93 | -2.59 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.2 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | 6 | Upgrade
|
| Investment in Securities | -530.49 | -334.87 | -13.3 | -135.59 | -231.3 | -105.58 | Upgrade
|
| Investing Cash Flow | -541.89 | -342.6 | -24.12 | -142.12 | -234.23 | -101.97 | Upgrade
|
| Issuance of Common Stock | 88.15 | 392.39 | 301.39 | 294.6 | 422.78 | 0.28 | Upgrade
|
| Repurchase of Common Stock | -4.03 | -4.03 | - | - | - | -0.05 | Upgrade
|
| Other Financing Activities | 840.83 | 840.83 | 0.04 | -0.42 | - | -1.6 | Upgrade
|
| Financing Cash Flow | 924.96 | 1,229 | 301.43 | 294.18 | 422.78 | 98.66 | Upgrade
|
| Net Cash Flow | -156.64 | 536.03 | 52.92 | 4.88 | 88.48 | -52.93 | Upgrade
|
| Free Cash Flow | -551.11 | -358.3 | -235.22 | -153.71 | -103 | -52.21 | Upgrade
|
| Free Cash Flow Margin | -74273.85% | -3094.14% | -664.83% | -522.99% | -239.62% | -104.32% | Upgrade
|
| Free Cash Flow Per Share | -3.45 | -3.17 | -2.92 | -2.11 | -1.88 | -18.83 | Upgrade
|
| Levered Free Cash Flow | -306.13 | -155.2 | -132.84 | -84.69 | -58.24 | -6.91 | Upgrade
|
| Unlevered Free Cash Flow | -305.94 | -155.01 | -132.84 | -84.68 | -58.19 | -6.84 | Upgrade
|
| Change in Net Working Capital | -4.3 | -70.19 | 1.45 | -11.29 | 1.51 | -17.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.